IRadimed Corporation (IRMD)
NASDAQ: IRMD · IEX Real-Time Price · USD
43.67
+0.23 (0.53%)
Jul 2, 2024, 4:00 PM EDT - Market closed
IRadimed Revenue
IRadimed had revenue of $67.69M in the twelve months ending March 31, 2024, with 19.87% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $17.60M with 13.72% year-over-year growth. In the year 2023, IRadimed had annual revenue of $65.56M with 23.00% growth.
Revenue (ttm)
$67.69M
Revenue Growth
+19.87%
P/S Ratio
8.17
Revenue / Employee
$457,333
Employees
148
Market Cap
553.05M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 65.56M | 12.26M | 23.00% |
Dec 31, 2022 | 53.30M | 11.49M | 27.48% |
Dec 31, 2021 | 41.81M | 10.10M | 31.83% |
Dec 31, 2020 | 31.72M | -6.80M | -17.65% |
Dec 31, 2019 | 38.52M | 8.08M | 26.54% |
Dec 31, 2018 | 30.44M | 7.36M | 31.88% |
Dec 31, 2017 | 23.08M | -9.41M | -28.97% |
Dec 31, 2016 | 32.50M | 902.83K | 2.86% |
Dec 31, 2015 | 31.59M | 15.94M | 101.84% |
Dec 31, 2014 | 15.65M | 4.31M | 38.03% |
Dec 31, 2013 | 11.34M | 3.66M | 47.56% |
Dec 31, 2012 | 7.69M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Clover Health Investments | 1.85B |
Travere Therapeutics | 183.23M |
Adaptive Biotechnologies | 174.50M |
SIGA Technologies | 157.02M |
Heron Therapeutics | 132.10M |
Y-mAbs Therapeutics | 84.50M |
OmniAb | 21.05M |
IRMD News
- 25 days ago - IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market - GlobeNewsWire
- 2 months ago - IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share - GlobeNewsWire
- 2 months ago - IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd - GlobeNewsWire
- 3 months ago - IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference - GlobeNewsWire
- 5 months ago - IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results - GlobeNewsWire
- 5 months ago - IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th. - GlobeNewsWire
- 6 months ago - IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue - GlobeNewsWire
- 6 months ago - IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire